BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21512074)

  • 41. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.
    Shirabe K; Itoh S; Yoshizumi T; Soejima Y; Taketomi A; Aishima S; Maehara Y
    J Surg Oncol; 2007 Mar; 95(3):235-40. PubMed ID: 17323337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
    Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings.
    Kanematsu M; Osada S; Amaoka N; Goshima S; Kondo H; Kato H; Nishibori H; Yokoyama R; Hoshi H; Moriyama N
    AJR Am J Roentgenol; 2005 Mar; 184(3):832-41. PubMed ID: 15728605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
    Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI findings of recurrent hepatocellular carcinoma after liver transplantation: preliminary results.
    Lee CH; Brubaker LM; Gerber DA; Ku YM; Kim YH; Shin SS; Semelka RC
    J Magn Reson Imaging; 2011 Jun; 33(6):1399-405. PubMed ID: 21591009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of matrix metalloproteinase-9 in predicting prognosis of hepatocellular carcinoma after liver transplantation.
    Nart D; Yaman B; Yilmaz F; Zeytunlu M; Karasu Z; Kiliç M
    Liver Transpl; 2010 May; 16(5):621-30. PubMed ID: 20440771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study.
    Cucchetti A; Piscaglia F; Grigioni AD; Ravaioli M; Cescon M; Zanello M; Grazi GL; Golfieri R; Grigioni WF; Pinna AD
    J Hepatol; 2010 Jun; 52(6):880-8. PubMed ID: 20409605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of clinical and pathological staging and long-term results of liver transplantation for hepatocellular carcinoma in a single transplant center.
    Baccarani U; Adani GL; Avellini C; Lorenzin D; Currò G; Beltrami A; Pasqualucci A; Bresadola V; Risaliti A; Viale PL; Beltrami CA; Bresadola F
    Transplant Proc; 2006 May; 38(4):1111-3. PubMed ID: 16757280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].
    Wang GY; Yang Y; Zhang Q; Li H; Chen GZ; Yi SH; Xu C; Wang GS; Zhang J; Yi HM; Jiang N; Fu BS; Zhao H; Li MR; Chen YH; Cai CJ; Lu MQ; Chen GH
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1519-22. PubMed ID: 21914362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver transplantation for patients with hepatocellular carcinoma.
    Ho MC; Wu YM; Hu RH; Ko WJ; Yang PM; Lai MY; Lin MH; Lin HY; Lee PH
    Transplant Proc; 2004 Oct; 36(8):2291-2. PubMed ID: 15561223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
    Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
    Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of Imaging Findings in the Prediction of Microvascular Invasion in Hepatocellular Carcinoma.
    Server S; Sabet S; Yaghouti K; Namal E; Inan N; Tokat Y
    Transplant Proc; 2019 Sep; 51(7):2403-2407. PubMed ID: 31402256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation.
    Nitta H; Allard MA; Sebagh M; Karam V; Ciacio O; Pittau G; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Guettier C; Samuel D; Baba H; Adam R
    Surgery; 2019 Jun; 165(6):1168-1175. PubMed ID: 30878140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor doubling time predicts recurrence after surgery and describes the histological pattern of hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Vivarelli M; Piscaglia F; Nardo B; Montalti R; Grazi GL; Ravaioli M; La Barba G; Cavallari A; Bolondi L; Pinna AD
    J Hepatol; 2005 Aug; 43(2):310-6. PubMed ID: 15970351
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.
    Pawlik TM; Gleisner AL; Anders RA; Assumpcao L; Maley W; Choti MA
    Ann Surg; 2007 Mar; 245(3):435-42. PubMed ID: 17435551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of hepatic venous trunk invasion and prognostic factors in patients with hepatocellular carcinomas that had come into contact with the trunk of major hepatic veins.
    Matsuda M; Suzuki T; Kono H; Fujii H
    J Hepatobiliary Pancreat Surg; 2007; 14(3):289-96. PubMed ID: 17520205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.